{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["5\u2032 AMP-activated protein kinase", "AMPK", "Lamiaceae", "NRF2", "PPAR\u03b3", "TGF-\u03b21", "Wnt", "erythroid 2-related factor 2", "fibrosis", "peroxisomal proliferator-activated receptor \u03b3", "rosmarinic acid", "transforming growth factor \u03b21"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38397744", "DateRevised": {"Year": "2024", "Month": "02", "Day": "27"}, "Article": {"Language": ["eng"], "ELocationID": ["146", "10.3390/antiox13020146"], "ArticleDate": [{"Year": "2024", "Month": "01", "Day": "24"}], "Journal": {"ISSN": "2076-3921", "JournalIssue": {"Volume": "13", "Issue": "2", "PubDate": {"Year": "2024", "Month": "Jan", "Day": "24"}}, "Title": "Antioxidants (Basel, Switzerland)", "ISOAbbreviation": "Antioxidants (Basel)"}, "ArticleTitle": "Therapeutic Potential and Mechanisms of Rosmarinic Acid and the Extracts of Lamiaceae Plants for the Treatment of Fibrosis of Various Organs.", "Abstract": {"AbstractText": ["Fibrosis, which causes structural hardening and functional degeneration in various organs, is characterized by the excessive production and accumulation of connective tissue containing collagen, alpha-smooth muscle actin (\u03b1-SMA), etc. In traditional medicine, extracts of medicinal plants or herbal prescriptions have been used to treat various fibrotic diseases. The purpose of this narrative review is to discuss the antifibrotic effects of rosmarinic acid (RA) and plant extracts that contain RA, as observed in various experimental models. RA, as well as the extracts of <i>Glechoma hederacea</i>, <i>Melissa officinalis</i>, <i>Elsholtzia ciliata</i>, <i>Lycopus lucidus</i>, <i>Ocimum basilicum</i>, <i>Prunella vulgaris</i>, <i>Salvia rosmarinus</i> (<i>Rosmarinus officinalis</i>), <i>Salvia miltiorrhiza</i>, and <i>Perilla frutescens</i>, have been shown to attenuate fibrosis of the liver, kidneys, heart, lungs, and abdomen in experimental animal models. Their antifibrotic effects were associated with the attenuation of oxidative stress, inflammation, cell activation, epithelial-mesenchymal transition, and fibrogenic gene expression. RA treatment activated peroxisomal proliferator-activated receptor gamma (PPAR\u03b3), 5' AMP-activated protein kinase (AMPK), and nuclear factor erythroid 2-related factor 2 (NRF2) while suppressing the transforming growth factor beta (TGF-\u03b2) and Wnt signaling pathways. Interestingly, most plants that are reported to contain RA and exhibit antifibrotic activity belong to the family Lamiaceae. This suggests that RA is an active ingredient for the antifibrotic effect of Lamiaceae plants and that these plants are a useful source of RA. In conclusion, accumulating scientific evidence supports the effectiveness of RA and Lamiaceae plant extracts in alleviating fibrosis and maintaining the structural architecture and normal functions of various organs under pathological conditions."]}, "AuthorList": [{"Identifier": ["0000-0001-9895-2066"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular Medicine, School of Medicine, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Republic of Korea."}, {"Identifier": [], "Affiliation": "BK21 Plus KNU Biomedical Convergence Program, Department of Biomedical Science, The Graduate School, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Republic of Korea."}, {"Identifier": [], "Affiliation": "Cell and Matrix Research Institute, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Republic of Korea."}], "LastName": "Boo", "ForeName": "Yong Chool", "Initials": "YC"}], "GrantList": [{"GrantID": "HP20C0004", "Agency": "Korea Health Industry Development Institute", "Country": "Republic of Korea"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Antioxidants (Basel)", "NlmUniqueID": "101668981", "ISSNLinking": "2076-3921"}, "CoiStatement": "The author declares no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Lee S.I., Kim H.J., Baek M.C., Park K.M., Park Y., Yoon C.H., Boo Y.C. Wen-pi-tang-Hab-Wu-ling-san, an oriental herbal prescription, attenuates epithelial-mesenchymal transdifferentiation stimulated by TGF-beta1 in kidney cells. Phytother. Res. 2007;21:548\u2013553. doi: 10.1002/ptr.2106.", "ArticleIdList": ["10.1002/ptr.2106", "17273984"]}, {"Citation": "Henderson N.C., Rieder F., Wynn T.A. Fibrosis: From mechanisms to medicines. Nature. 2020;587:555\u2013566. doi: 10.1038/s41586-020-2938-9.", "ArticleIdList": ["10.1038/s41586-020-2938-9", "PMC8034822", "33239795"]}, {"Citation": "Antar S.A., Ashour N.A., Marawan M.E., Al-Karmalawy A.A. Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation. Int. J. Mol. Sci. 2023;24:4004. doi: 10.3390/ijms24044004.", "ArticleIdList": ["10.3390/ijms24044004", "PMC9963026", "36835428"]}, {"Citation": "Lurje I., Gaisa N.T., Weiskirchen R., Tacke F. Mechanisms of organ fibrosis: Emerging concepts and implications for novel treatment strategies. Mol. Asp. Med. 2023;92:101191. doi: 10.1016/j.mam.2023.101191.", "ArticleIdList": ["10.1016/j.mam.2023.101191", "37236017"]}, {"Citation": "Gyorfi A.H., Matei A.E., Distler J.H.W. Targeting TGF-beta signaling for the treatment of fibrosis. Matrix Biol. 2018;68\u201369:8\u201327. doi: 10.1016/j.matbio.2017.12.016.", "ArticleIdList": ["10.1016/j.matbio.2017.12.016", "29355590"]}, {"Citation": "Distler J.H.W., Gyorfi A.H., Ramanujam M., Whitfield M.L., Konigshoff M., Lafyatis R. Shared and distinct mechanisms of fibrosis. Nat. Rev. Rheumatol. 2019;15:705\u2013730. doi: 10.1038/s41584-019-0322-7.", "ArticleIdList": ["10.1038/s41584-019-0322-7", "31712723"]}, {"Citation": "Tan Z., Sun H., Xue T., Gan C., Liu H., Xie Y., Yao Y., Ye T. Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy. Front. Cell Dev. Biol. 2021;9:730176. doi: 10.3389/fcell.2021.730176.", "ArticleIdList": ["10.3389/fcell.2021.730176", "PMC8490799", "34621747"]}, {"Citation": "Sato S., Yanagihara T., Kolb M.R.J. Therapeutic targets and early stage clinical trials for pulmonary fibrosis. Expert Opin. Investig. Drugs. 2019;28:19\u201328. doi: 10.1080/13543784.2019.1554054.", "ArticleIdList": ["10.1080/13543784.2019.1554054", "30513000"]}, {"Citation": "Rayego-Mateos S., Valdivielso J.M. New therapeutic targets in chronic kidney disease progression and renal fibrosis. Expert Opin. Ther. Targets. 2020;24:655\u2013670. doi: 10.1080/14728222.2020.1762173.", "ArticleIdList": ["10.1080/14728222.2020.1762173", "32338087"]}, {"Citation": "Park S., Nguyen N.B., Pezhouman A., Ardehali R. Cardiac fibrosis: Potential therapeutic targets. Transl. Res. 2019;209:121\u2013137. doi: 10.1016/j.trsl.2019.03.001.", "ArticleIdList": ["10.1016/j.trsl.2019.03.001", "PMC6545256", "30930180"]}, {"Citation": "Latief U., Ahmad R. Herbal remedies for liver fibrosis: A review on the mode of action of fifty herbs. J. Tradit. Complement. Med. 2018;8:352\u2013360. doi: 10.1016/j.jtcme.2017.07.002.", "ArticleIdList": ["10.1016/j.jtcme.2017.07.002", "PMC6035307", "29992106"]}, {"Citation": "Xu Y., Chen J., Wang H., Lu Y. Research and application of herbal medicine in the treatment of chronic kidney disease since the 21st century: A visualized bibliometric analysis. Front. Pharmacol. 2022;13:971113. doi: 10.3389/fphar.2022.971113.", "ArticleIdList": ["10.3389/fphar.2022.971113", "PMC9561987", "36249821"]}, {"Citation": "Wu X., Huang J., Wang J., Xu Y., Yang X., Sun M., Shi J. Multi-Pharmaceutical Activities of Chinese Herbal Polysaccharides in the Treatment of Pulmonary Fibrosis: Concept and Future Prospects. Front. Pharmacol. 2021;12:707491. doi: 10.3389/fphar.2021.707491.", "ArticleIdList": ["10.3389/fphar.2021.707491", "PMC8418122", "34489700"]}, {"Citation": "Wang L., Zhu T., Feng D., Li R., Zhang C. Polyphenols from Chinese Herbal Medicine: Molecular Mechanisms and Therapeutic Targets in Pulmonary Fibrosis. Am. J. Chin. Med. 2022;50:1063\u20131094. doi: 10.1142/S0192415X22500434.", "ArticleIdList": ["10.1142/S0192415X22500434", "35475972"]}, {"Citation": "Li S., Tan H.Y., Wang N., Cheung F., Hong M., Feng Y. The Potential and Action Mechanism of Polyphenols in the Treatment of Liver Diseases. Oxid. Med. Cell Longev. 2018;2018:8394818. doi: 10.1155/2018/8394818.", "ArticleIdList": ["10.1155/2018/8394818", "PMC5817364", "29507653"]}, {"Citation": "Zhou Z., Qiao Y., Zhao Y., Chen X., Li J., Zhang H., Lan Q., Yang B. Natural products: Potential drugs for the treatment of renal fibrosis. Chin. Med. 2022;17:98. doi: 10.1186/s13020-022-00646-z.", "ArticleIdList": ["10.1186/s13020-022-00646-z", "PMC9386947", "35978370"]}, {"Citation": "Alberti A. Importance of dietary hydroxycinnamic acids in the therapy of liver fibrosis. Orv. Hetil. 2012;153:948\u2013953. doi: 10.1556/OH.2012.29401.", "ArticleIdList": ["10.1556/OH.2012.29401", "22695630"]}, {"Citation": "Elufioye T.O., Habtemariam S. Hepatoprotective effects of rosmarinic acid: Insight into its mechanisms of action. Biomed. Pharmacother. 2019;112:108600. doi: 10.1016/j.biopha.2019.108600.", "ArticleIdList": ["10.1016/j.biopha.2019.108600", "30780110"]}, {"Citation": "Guan H., Luo W., Bao B., Cao Y., Cheng F., Yu S., Fan Q., Zhang L., Wu Q., Shan M. A Comprehensive Review of Rosmarinic Acid: From Phytochemistry to Pharmacology and Its New Insight. Molecules. 2022;27:3292. doi: 10.3390/molecules27103292.", "ArticleIdList": ["10.3390/molecules27103292", "PMC9143754", "35630768"]}, {"Citation": "Nieto G., Ros G., Castillo J. Antioxidant and Antimicrobial Properties of Rosemary (Rosmarinus officinalis, L.): A Review. Medicines. 2018;5:98. doi: 10.3390/medicines5030098.", "ArticleIdList": ["10.3390/medicines5030098", "PMC6165352", "30181448"]}, {"Citation": "Dahchour A. Anxiolytic and antidepressive potentials of rosmarinic acid: A review with a focus on antioxidant and anti-inflammatory effects. Pharmacol. Res. 2022;184:106421. doi: 10.1016/j.phrs.2022.106421.", "ArticleIdList": ["10.1016/j.phrs.2022.106421", "36096427"]}, {"Citation": "Luo C., Zou L., Sun H., Peng J., Gao C., Bao L., Ji R., Jin Y., Sun S. A Review of the Anti-Inflammatory Effects of Rosmarinic Acid on Inflammatory Diseases. Front. Pharmacol. 2020;11:153. doi: 10.3389/fphar.2020.00153.", "ArticleIdList": ["10.3389/fphar.2020.00153", "PMC7059186", "32184728"]}, {"Citation": "Noor S., Mohammad T., Rub M.A., Raza A., Azum N., Yadav D.K., Hassan M.I., Asiri A.M. Biomedical features and therapeutic potential of rosmarinic acid. Arch. Pharm. Res. 2022;45:205\u2013228. doi: 10.1007/s12272-022-01378-2.", "ArticleIdList": ["10.1007/s12272-022-01378-2", "PMC8989115", "35391712"]}, {"Citation": "Zhao J., Xu L., Jin D., Xin Y., Tian L., Wang T., Zhao D., Wang Z., Wang J. Rosmarinic Acid and Related Dietary Supplements: Potential Applications in the Prevention and Treatment of Cancer. Biomolecules. 2022;12:1410. doi: 10.3390/biom12101410.", "ArticleIdList": ["10.3390/biom12101410", "PMC9599057", "36291619"]}, {"Citation": "Azhar M.K., Anwar S., Hasan G.M., Shamsi A., Islam A., Parvez S., Hassan M.I. Comprehensive Insights into Biological Roles of Rosmarinic Acid: Implications in Diabetes, Cancer and Neurodegenerative Diseases. Nutrients. 2023;15:4297. doi: 10.3390/nu15194297.", "ArticleIdList": ["10.3390/nu15194297", "PMC10574478", "37836581"]}, {"Citation": "Budi E.H., Schaub J.R., Decaris M., Turner S., Derynck R. TGF-\u03b2 as a driver of fibrosis: Physiological roles and therapeutic opportunities. J. Pathol. 2021;254:358\u2013373. doi: 10.1002/path.5680.", "ArticleIdList": ["10.1002/path.5680", "33834494"]}, {"Citation": "Tie Y., Tang F., Peng D., Zhang Y., Shi H. TGF-beta signal transduction: Biology, function and therapy for diseases. Mol. Biomed. 2022;3:45. doi: 10.1186/s43556-022-00109-9.", "ArticleIdList": ["10.1186/s43556-022-00109-9", "PMC9761655", "36534225"]}, {"Citation": "Klinkhammer B.M., Floege J., Boor P. PDGF in organ fibrosis. Mol. Asp. Med. 2018;62:44\u201362. doi: 10.1016/j.mam.2017.11.008.", "ArticleIdList": ["10.1016/j.mam.2017.11.008", "29155002"]}, {"Citation": "Zou X., Tang X.Y., Qu Z.Y., Sun Z.W., Ji C.F., Li Y.J., Guo S.D. Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review. Int. J. Biol. Macromol. 2022;202:539\u2013557. doi: 10.1016/j.ijbiomac.2022.01.113.", "ArticleIdList": ["10.1016/j.ijbiomac.2022.01.113", "35074329"]}, {"Citation": "Reyhani V., Tsioumpekou M., van Wieringen T., Rask L., Lennartsson J., Rubin K. PDGF-BB enhances collagen gel contraction through a PI3K-PLC\u03b3-PKC-cofilin pathway. Sci. Rep. 2017;7:8924. doi: 10.1038/s41598-017-08411-1.", "ArticleIdList": ["10.1038/s41598-017-08411-1", "PMC5566449", "28827622"]}, {"Citation": "Wang J., You J., Gong D., Xu Y., Yang B., Jiang C. PDGF-BB induces conversion, proliferation, migration, and collagen synthesis of oral mucosal fibroblasts through PDGFR-beta/PI3K/ AKT signaling pathway. Cancer Biomark. 2021;30:407\u2013415. doi: 10.3233/CBM-201681.", "ArticleIdList": ["10.3233/CBM-201681", "33492283"]}, {"Citation": "Takamura N., Renaud L., da Silveira W.A., Feghali-Bostwick C. PDGF Promotes Dermal Fibroblast Activation via a Novel Mechanism Mediated by Signaling Through MCHR1. Front. Immunol. 2021;12:745308. doi: 10.3389/fimmu.2021.745308.", "ArticleIdList": ["10.3389/fimmu.2021.745308", "PMC8667318", "34912333"]}, {"Citation": "Yao L., Rathnakar B.H., Kwon H.R., Sakashita H., Kim J.H., Rackley A., Tomasek J.J., Berry W.L., Olson L.E. Temporal control of PDGFRalpha regulates the fibroblast-to-myofibroblast transition in wound healing. Cell Rep. 2022;40:111192. doi: 10.1016/j.celrep.2022.111192.", "ArticleIdList": ["10.1016/j.celrep.2022.111192", "PMC9423027", "35977484"]}, {"Citation": "Zhang F., Kong D., Chen L., Zhang X., Lian N., Zhu X., Lu Y., Zheng S. Peroxisome proliferator-activated receptor-gamma interrupts angiogenic signal transduction by transrepression of platelet-derived growth factor-beta receptor in hepatic stellate cells. J. Cell Sci. 2014;127:305\u2013314.", "ArticleIdList": ["24259663"]}, {"Citation": "Kikuchi A., Pradhan-Sundd T., Singh S., Nagarajan S., Loizos N., Monga S.P. Platelet-Derived Growth Factor Receptor alpha Contributes to Human Hepatic Stellate Cell Proliferation and Migration. Am. J. Pathol. 2017;187:2273\u20132287. doi: 10.1016/j.ajpath.2017.06.009.", "ArticleIdList": ["10.1016/j.ajpath.2017.06.009", "PMC5809633", "28734947"]}, {"Citation": "Lipson K.E., Wong C., Teng Y., Spong S. CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis. Fibrogenesis Tissue Repair. 2012;5:S24. doi: 10.1186/1755-1536-5-S1-S24.", "ArticleIdList": ["10.1186/1755-1536-5-S1-S24", "PMC3368796", "23259531"]}, {"Citation": "Chen Z., Zhang N., Chu H.Y., Yu Y., Zhang Z.K., Zhang G., Zhang B.T. Connective Tissue Growth Factor: From Molecular Understandings to Drug Discovery. Front. Cell Dev. Biol. 2020;8:593269. doi: 10.3389/fcell.2020.593269.", "ArticleIdList": ["10.3389/fcell.2020.593269", "PMC7658337", "33195264"]}, {"Citation": "Fu M., Peng D., Lan T., Wei Y., Wei X. Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases. Acta Pharm. Sin. B. 2022;12:1740\u20131760. doi: 10.1016/j.apsb.2022.01.007.", "ArticleIdList": ["10.1016/j.apsb.2022.01.007", "PMC9279711", "35847511"]}, {"Citation": "Liu R., Zhu M., Chen J., Gai J., Huang J., Zhou Y., Wan Y., Tu C. Identification and Characterization of a Novel Nanobody Against Human CTGF to Reveal Its Antifibrotic Effect in an in vitro Model of Liver Fibrosis. Int. J. Nanomed. 2023;18:5407\u20135422. doi: 10.2147/IJN.S428430.", "ArticleIdList": ["10.2147/IJN.S428430", "PMC10519214", "37753068"]}, {"Citation": "Trampuz S.R., van Riet S., Nordling A., Ingelman-Sundberg M. The Role of CTGF in Liver Fibrosis Induced in 3D Human Liver Spheroids. Cells. 2023;12:302. doi: 10.3390/cells12020302.", "ArticleIdList": ["10.3390/cells12020302", "PMC9857203", "36672237"]}, {"Citation": "Barbe M.F., Hilliard B.A., Amin M., Harris M.Y., Hobson L.J., Cruz G.E., Popoff S.N. Blocking CTGF/CCN2 reduces established skeletal muscle fibrosis in a rat model of overuse injury. FASEB J. 2020;34:6554\u20136569. doi: 10.1096/fj.202000240RR.", "ArticleIdList": ["10.1096/fj.202000240RR", "PMC7200299", "32227398"]}, {"Citation": "Liu J.Q., Xiao Q., Xiao J.N., Niu C.X., Li Y.Y., Zhang X.J., Zhou Z.W., Shu G., Yin G. Wnt/\u03b2-catenin signalling: Function, biological mechanisms, and therapeutic opportunities. Signal Transduct. Target. Ther. 2022;7:3. doi: 10.1038/s41392-021-00762-6.", "ArticleIdList": ["10.1038/s41392-021-00762-6", "PMC8724284", "34980884"]}, {"Citation": "Jiang Y.G., Luo Y., He D.L., Li X., Zhang L.L., Peng T., Li M.C., Lin Y.H. Role of Wnt/\u03b2-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1\u03b1. Int. J. Urol. 2007;14:1034\u20131039. doi: 10.1111/j.1442-2042.2007.01866.x.", "ArticleIdList": ["10.1111/j.1442-2042.2007.01866.x", "17956532"]}, {"Citation": "Lyros O., Rafiee P., Nie L.H., Medda R., Jovanovic N., Schmidt J., Mackinnon A., Venu N., Shaker R. Dickkopf-1, the Wnt antagonist, is induced by acidic pH and mediates epithelial cellular senescence in human reflux esophagitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2014;306:G557\u2013G574. doi: 10.1152/ajpgi.00153.2013.", "ArticleIdList": ["10.1152/ajpgi.00153.2013", "PMC3962590", "24481601"]}, {"Citation": "Akhmetshina A., Palumbo K., Dees C., Bergmann C., Venalis P., Zerr P., Horn A., Kireva T., Beyer C., Zwerina J., et al. Activation of canonical Wnt signalling is required for TGF-\u03b2-mediated fibrosis. Nat. Commun. 2012;3:735. doi: 10.1038/ncomms1734.", "ArticleIdList": ["10.1038/ncomms1734", "PMC3316881", "22415826"]}, {"Citation": "Zhang X., Zhang X., Huang W., Ge X. The role of heat shock proteins in the regulation of fibrotic diseases. Biomed. Pharmacother. 2021;135:111067. doi: 10.1016/j.biopha.2020.111067.", "ArticleIdList": ["10.1016/j.biopha.2020.111067", "33383375"]}, {"Citation": "Bunch H., Calderwood S.K. Role of Heat Shock Factors in Stress-Induced Transcription: An Update. Methods Mol. Biol. 2023;2693:25\u201338.", "ArticleIdList": ["37540424"]}, {"Citation": "Kmiecik S.W., Mayer M.P. Molecular mechanisms of heat shock factor 1 regulation. Trends Biochem. Sci. 2022;47:218\u2013234. doi: 10.1016/j.tibs.2021.10.004.", "ArticleIdList": ["10.1016/j.tibs.2021.10.004", "34810080"]}, {"Citation": "Li L., Wu T., Huang J., Ma K., Xu L., Wang H., Fan X., Tao R., Ai G., Ning Q. Expression of heat shock protein 47, transforming growth factor-beta 1, and connective tissue growth factor in liver tissue of patients with Schistosoma japonicum-induced hepatic fibrosis. Parasitology. 2015;142:341\u2013351. doi: 10.1017/S0031182014001115.", "ArticleIdList": ["10.1017/S0031182014001115", "25111595"]}, {"Citation": "Lonsmann I., Gudmann N.S., Manon-Jensen T., Thiele M., Moreno Y.M., Langholm L.L., Nielsen M.J., Detlefsen S., Karsdal M.A., Krag A.A., et al. Serologically assessed heat shock protein 47 is related to fibrosis stage in early compensated alcohol-related liver disease. Clin. Biochem. 2022;104:36\u201343. doi: 10.1016/j.clinbiochem.2021.12.008.", "ArticleIdList": ["10.1016/j.clinbiochem.2021.12.008", "34929150"]}, {"Citation": "Bellaye P.S., Burgy O., Bonniaud P., Kolb M. HSP47: A potential target for fibrotic diseases and implications for therapy. Expert Opin. Ther. Targets. 2021;25:49\u201362. doi: 10.1080/14728222.2021.1861249.", "ArticleIdList": ["10.1080/14728222.2021.1861249", "33287600"]}, {"Citation": "Vidyasagar A., Wilson N.A., Djamali A. Heat shock protein 27 (HSP27): Biomarker of disease and therapeutic target. Fibrogenesis Tissue Repair. 2012;5:7. doi: 10.1186/1755-1536-5-7.", "ArticleIdList": ["10.1186/1755-1536-5-7", "PMC3464729", "22564335"]}, {"Citation": "Park A.M., Kanai K., Itoh T., Sato T., Tsukui T., Inagaki Y., Selman M., Matsushima K., Yoshie O. Heat Shock Protein 27 Plays a Pivotal Role in Myofibroblast Differentiation and in the Development of Bleomycin-Induced Pulmonary Fibrosis. PLoS ONE. 2016;11:e0148998. doi: 10.1371/journal.pone.0148998.", "ArticleIdList": ["10.1371/journal.pone.0148998", "PMC4747463", "26859835"]}, {"Citation": "Richter K., Kietzmann T. Reactive oxygen species and fibrosis: Further evidence of a significant liaison. Cell Tissue Res. 2016;365:591\u2013605. doi: 10.1007/s00441-016-2445-3.", "ArticleIdList": ["10.1007/s00441-016-2445-3", "PMC5010605", "27345301"]}, {"Citation": "Sies H., Jones D.P. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat. Rev. Mol. Cell Biol. 2020;21:363\u2013383. doi: 10.1038/s41580-020-0230-3.", "ArticleIdList": ["10.1038/s41580-020-0230-3", "32231263"]}, {"Citation": "Forman H.J., Zhang H.Q. Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy. Nat. Rev. Drug Discov. 2021;20:689\u2013709. doi: 10.1038/s41573-021-00233-1.", "ArticleIdList": ["10.1038/s41573-021-00233-1", "PMC8243062", "34194012"]}, {"Citation": "Morry J., Ngamcherdtrakul W., Yantasee W. Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles. Redox Biol. 2017;11:240\u2013253. doi: 10.1016/j.redox.2016.12.011.", "ArticleIdList": ["10.1016/j.redox.2016.12.011", "PMC5198743", "28012439"]}, {"Citation": "Saso L., Reza A., Ng E., Nguyen K., Lin S., Zhang P.Z., Fantozzi P.J., Armagan G., Romeo U., Cirillo N. A Comprehensive Analysis of the Role of Oxidative Stress in the Pathogenesis and Chemoprevention of Oral Submucous Fibrosis. Antioxidants. 2022;11:868. doi: 10.3390/antiox11050868.", "ArticleIdList": ["10.3390/antiox11050868", "PMC9137539", "35624733"]}, {"Citation": "Wang R.S., Wang S., Liang J.W., Li T., Zhou L., Zhan Z.L., Wan X.F., Kang C.Z., Guo L.P. Cloning and functional analysis of caffeic acid and rosmarinic acid glycosyltransferases from Arnebia euchroma. Zhongguo Zhong Yao Za Zhi. 2021;46:86\u201393.", "ArticleIdList": ["33645056"]}, {"Citation": "Westra I.M., Oosterhuis D., Groothuis G.M., Olinga P. Precision-cut liver slices as a model for the early onset of liver fibrosis to test antifibrotic drugs. Toxicol. Appl. Pharmacol. 2014;274:328\u2013338. doi: 10.1016/j.taap.2013.11.017.", "ArticleIdList": ["10.1016/j.taap.2013.11.017", "24321339"]}, {"Citation": "Westra I.M., Oosterhuis D., Groothuis G.M., Olinga P. The effect of antifibrotic drugs in rat precision-cut fibrotic liver slices. PLoS ONE. 2014;9:e95462. doi: 10.1371/journal.pone.0095462.", "ArticleIdList": ["10.1371/journal.pone.0095462", "PMC3995767", "24755660"]}, {"Citation": "Westra I.M., Mutsaers H.A., Luangmonkong T., Hadi M., Oosterhuis D., de Jong K.P., Groothuis G.M., Olinga P. Human precision-cut liver slices as a model to test antifibrotic drugs in the early onset of liver fibrosis. Toxicol. Vitr. 2016;35:77\u201385. doi: 10.1016/j.tiv.2016.05.012.", "ArticleIdList": ["10.1016/j.tiv.2016.05.012", "27235791"]}, {"Citation": "Iswandana R., Pham B.T., van Haaften W.T., Luangmonkong T., Oosterhuis D., Mutsaers H.A., Olinga P. Organ- and species-specific biological activity of rosmarinic acid. Toxicol. Vitr. 2016;32:261\u2013268. doi: 10.1016/j.tiv.2016.01.009.", "ArticleIdList": ["10.1016/j.tiv.2016.01.009", "26804033"]}, {"Citation": "Li G.S., Jiang W.L., Tian J.W., Qu G.W., Zhu H.B., Fu F.H. In vitro and in vivo antifibrotic effects of rosmarinic acid on experimental liver fibrosis. Phytomedicine. 2010;17:282\u2013288. doi: 10.1016/j.phymed.2009.05.002.", "ArticleIdList": ["10.1016/j.phymed.2009.05.002", "19524418"]}, {"Citation": "Yang M.D., Chiang Y.M., Higashiyama R., Asahina K., Mann D.A., Mann J., Wang C.C., Tsukamoto H. Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor gamma in hepatic stellate cells for their antifibrotic effect. Hepatology. 2012;55:1271\u20131281. doi: 10.1002/hep.24792.", "ArticleIdList": ["10.1002/hep.24792", "PMC3302956", "22095555"]}, {"Citation": "Wang Y.Y., Lin S.Y., Chen W.Y., Liao S.L., Wu C.C., Pan P.H., Chou S.T., Chen C.J. Glechoma hederacea extracts attenuate cholestatic liver injury in a bile duct-ligated rat model. J. Ethnopharmacol. 2017;204:58\u201366. doi: 10.1016/j.jep.2017.04.011.", "ArticleIdList": ["10.1016/j.jep.2017.04.011", "28416441"]}, {"Citation": "Lin S.Y., Wang Y.Y., Chen W.Y., Liao S.L., Chou S.T., Yang C.P., Chen C.J. Hepatoprotective activities of rosmarinic acid against extrahepatic cholestasis in rats. Food Chem. Toxicol. 2017;108:214\u2013223. doi: 10.1016/j.fct.2017.08.005.", "ArticleIdList": ["10.1016/j.fct.2017.08.005", "28789951"]}, {"Citation": "El-Lakkany N.M., El-Maadawy W.H., Seif El-Din S.H., Hammam O.A., Mohamed S.H., Ezzat S.M., Safar M.M., Saleh S. Rosmarinic acid attenuates hepatic fibrogenesis via suppression of hepatic stellate cell activation/proliferation and induction of apoptosis. Asian Pac. J. Trop. Med. 2017;10:444\u2013453. doi: 10.1016/j.apjtm.2017.05.012.", "ArticleIdList": ["10.1016/j.apjtm.2017.05.012", "28647181"]}, {"Citation": "Kim M., Yoo G., Randy A., Son Y.J., Hong C.R., Kim S.M., Nho C.W. Lemon Balm and Its Constituent, Rosmarinic Acid, Alleviate Liver Damage in an Animal Model of Nonalcoholic Steatohepatitis. Nutrients. 2020;12:1166. doi: 10.3390/nu12041166.", "ArticleIdList": ["10.3390/nu12041166", "PMC7230626", "32331258"]}, {"Citation": "Lyu C., Kong W., Liu Z., Wang S., Zhao P., Liang K., Niu Y., Yang W., Xiang C., Hu X., et al. Advanced glycation end-products as mediators of the aberrant crosslinking of extracellular matrix in scarred liver tissue. Nat. Biomed. Eng. 2023;7:1437\u20131454. doi: 10.1038/s41551-023-01019-z.", "ArticleIdList": ["10.1038/s41551-023-01019-z", "37037967"]}, {"Citation": "Seok Y.M., Kim J., Choi K.C., Yoon C.H., Boo Y.C., Park Y., Park K.M. Wen-pi-tang-Hab-Wu-ling-san attenuates kidney ischemia/reperfusion injury in mice A role for antioxidant enzymes and heat-shock proteins. J. Ethnopharmacol. 2007;111:333. doi: 10.1016/j.jep.2007.03.015.", "ArticleIdList": ["10.1016/j.jep.2007.03.015", "17446018"]}, {"Citation": "Seok Y.M., Kim J., Park M.J., Boo Y.C., Park Y.K., Park K.M. Wen-pi-tang-Hab-Wu-ling-san attenuates kidney fibrosis induced by ischemia/reperfusion in mice. Phytother. Res. 2008;22:1057. doi: 10.1002/ptr.2440.", "ArticleIdList": ["10.1002/ptr.2440", "18570213"]}, {"Citation": "Jung K.J., Kim J., Park Y.K., Yoon Y.R., Park K.M. Wen-pi-tang-Hab-Wu-ling-san reduces ureteral obstructive renal fibrosis by the reduction of oxidative stress, inflammation, and TGF-beta/Smad2/3 signaling. Food Chem. Toxicol. 2010;48:522\u2013529. doi: 10.1016/j.fct.2009.11.006.", "ArticleIdList": ["10.1016/j.fct.2009.11.006", "19913069"]}, {"Citation": "Kim T.W., Kim Y.J., Seo C.S., Kim H.T., Park S.R., Lee M.Y., Jung J.Y. Elsholtzia ciliata (Thunb.) Hylander attenuates renal inflammation and interstitial fibrosis via regulation of TGF-ss and Smad3 expression on unilateral ureteral obstruction rat model. Phytomedicine. 2016;23:331\u2013339. doi: 10.1016/j.phymed.2016.01.013.", "ArticleIdList": ["10.1016/j.phymed.2016.01.013", "27002403"]}, {"Citation": "Hsieh Y.H., Tsai J.P., Ting Y.H., Hung T.W., Chao W.W. Rosmarinic acid ameliorates renal interstitial fibrosis by inhibiting the phosphorylated-AKT mediated epithelial-mesenchymal transition in vitro and in vivo. Food Funct. 2022;13:4641\u20134652. doi: 10.1039/D2FO00204C.", "ArticleIdList": ["10.1039/D2FO00204C", "35373225"]}, {"Citation": "Joardar S., Dewanjee S., Bhowmick S., Dua T.K., Das S., Saha A., De Feo V. Rosmarinic Acid Attenuates Cadmium-Induced Nephrotoxicity via Inhibition of Oxidative Stress, Apoptosis, Inflammation and Fibrosis. Int. J. Mol. Sci. 2019;20:2027. doi: 10.3390/ijms20082027.", "ArticleIdList": ["10.3390/ijms20082027", "PMC6514581", "31022990"]}, {"Citation": "Yao Y., Yang J., Wang D., Zhou F., Cai X., Lu W., Hu C., Gu Z., Qian S., Guan X., et al. The aqueous extract of Lycopus lucidus Turcz ameliorates streptozotocin-induced diabetic renal damage via inhibiting TGF-beta1 signaling pathway. Phytomedicine. 2013;20:1160\u20131167. doi: 10.1016/j.phymed.2013.06.004.", "ArticleIdList": ["10.1016/j.phymed.2013.06.004", "23827664"]}, {"Citation": "Wang C., Zhou J., Wang S., Liu Y., Long K., Sun T., Zhi W., Yang Y., Zhang H., Zhao Y., et al. Guanxining injection alleviates fibrosis in heart failure mice and regulates SLC7A11/GPX4 axis. J. Ethnopharmacol. 2023;310:116367. doi: 10.1016/j.jep.2023.116367.", "ArticleIdList": ["10.1016/j.jep.2023.116367", "36914037"]}, {"Citation": "Fathiazad F., Matlobi A., Khorrami A., Hamedeyazdan S., Soraya H., Hammami M., Maleki-Dizaji N., Garjani A. Phytochemical screening and evaluation of cardioprotective activity of ethanolic extract of Ocimum basilicum L. (basil) against isoproterenol induced myocardial infarction in rats. Daru. 2012;20:87. doi: 10.1186/2008-2231-20-87.", "ArticleIdList": ["10.1186/2008-2231-20-87", "PMC3556047", "23351503"]}, {"Citation": "Wei J., Leng L., Sui Y., Song S., Owusu F.B., Li X., Cao Y., Li P., Wang H., Li R., et al. Phenolic acids from Prunella vulgaris alleviate cardiac remodeling following myocardial infarction partially by suppressing NLRP3 activation. Phytother. Res. 2024;38:384\u2013399. doi: 10.1002/ptr.8024.", "ArticleIdList": ["10.1002/ptr.8024", "37992723"]}, {"Citation": "Liu Q., Tian J., Xu Y., Li C., Meng X., Fu F. Protective Effect of RA on Myocardial Infarction-Induced Cardiac Fibrosis via AT1R/p38 MAPK Pathway Signaling and Modulation of the ACE2/ACE Ratio. J. Agric. Food Chem. 2016;64:6716\u20136722. doi: 10.1021/acs.jafc.6b03001.", "ArticleIdList": ["10.1021/acs.jafc.6b03001", "27538767"]}, {"Citation": "Zhang L., Bei Z., Li T., Qian Z. An injectable conductive hydrogel with dual responsive release of rosmarinic acid improves cardiac function and promotes repair after myocardial infarction. Bioact. Mater. 2023;29:132\u2013150. doi: 10.1016/j.bioactmat.2023.07.007.", "ArticleIdList": ["10.1016/j.bioactmat.2023.07.007", "PMC10444974", "37621769"]}, {"Citation": "Zhang X., Ma Z.G., Yuan Y.P., Xu S.C., Wei W.Y., Song P., Kong C.Y., Deng W., Tang Q.Z. Rosmarinic acid attenuates cardiac fibrosis following long-term pressure overload via AMPKalpha/Smad3 signaling. Cell Death Dis. 2018;9:102. doi: 10.1038/s41419-017-0123-3.", "ArticleIdList": ["10.1038/s41419-017-0123-3", "PMC5833382", "29367637"]}, {"Citation": "Rahbardar M.G., Eisvand F., Rameshrad M., Razavi B.M., Hosseinzadeh H. In Vivo and In Vitro Protective Effects of Rosmarinic Acid against Doxorubicin-Induced Cardiotoxicity. Nutr. Cancer. 2022;74:747\u2013760. doi: 10.1080/01635581.2021.1931362.", "ArticleIdList": ["10.1080/01635581.2021.1931362", "34085575"]}, {"Citation": "Bahri S., Ben Ali R., Gasmi K., Mlika M., Fazaa S., Ksouri R., Serairi R., Jameleddine S., Shlyonsky V. Prophylactic and curative effect of rosemary leaves extract in a bleomycin model of pulmonary fibrosis. Pharm. Biol. 2017;55:462\u2013471. doi: 10.1080/13880209.2016.1247881.", "ArticleIdList": ["10.1080/13880209.2016.1247881", "PMC6130597", "28093019"]}, {"Citation": "Bahri S., Mies F., Ben Ali R., Mlika M., Jameleddine S., Mc Entee K., Shlyonsky V. Rosmarinic acid potentiates carnosic acid induced apoptosis in lung fibroblasts. PLoS ONE. 2017;12:e0184368. doi: 10.1371/journal.pone.0184368.", "ArticleIdList": ["10.1371/journal.pone.0184368", "PMC5587316", "28877257"]}, {"Citation": "Zhang T., Ma S., Liu C., Hu K., Xu M., Wang R. Rosmarinic Acid Prevents Radiation-Induced Pulmonary Fibrosis through Attenuation of ROS/MYPT1/TGFbeta1 Signaling Via miR-19b-3p. Dose Response. 2020;18:1559325820968413. doi: 10.1177/1559325820968413.", "ArticleIdList": ["10.1177/1559325820968413", "PMC7580151", "33149731"]}, {"Citation": "Luo J., Zhang L., Zhang X., Long Y., Zou F., Yan C., Zou W. Protective effects and active ingredients of Salvia miltiorrhiza Bunge extracts on airway responsiveness, inflammation and remodeling in mice with ovalbumin-induced allergic asthma. Phytomedicine. 2019;52:168\u2013177. doi: 10.1016/j.phymed.2018.09.170.", "ArticleIdList": ["10.1016/j.phymed.2018.09.170", "30599896"]}, {"Citation": "Shakeri F., Eftekhar N., Roshan N.M., Rezaee R., Moghimi A., Boskabady M.H. Rosmarinic acid affects immunological and inflammatory mediator levels and restores lung pathological features in asthmatic rats. Allergol. Immunopathol. 2019;47:16\u201323. doi: 10.1016/j.aller.2018.04.004.", "ArticleIdList": ["10.1016/j.aller.2018.04.004", "29983238"]}, {"Citation": "Kakanezhadi A., Rezaei M., Raisi A., Dezfoulian O., Davoodi F., Ahmadvand H. Rosmarinic acid prevents post-operative abdominal adhesions in a rat model. Sci. Rep. 2022;12:18593. doi: 10.1038/s41598-022-22000-x.", "ArticleIdList": ["10.1038/s41598-022-22000-x", "PMC9633689", "36329196"]}, {"Citation": "Peng H.H., Chen Y.M., Lee C.I., Lee M.W. Synthesis of a disulfide cross-linked polygalacturonic acid hydrogel for biomedical applications. J. Mater. Sci. Mater. Med. 2013;24:1375\u20131382. doi: 10.1007/s10856-013-4901-x.", "ArticleIdList": ["10.1007/s10856-013-4901-x", "23468164"]}, {"Citation": "Zhang T., Liu C., Ma S., Gao Y., Wang R. Protective Effect and Mechanism of Action of Rosmarinic Acid on Radiation-Induced Parotid Gland Injury in Rats. Dose Response. 2020;18:1559325820907782. doi: 10.1177/1559325820907782.", "ArticleIdList": ["10.1177/1559325820907782", "PMC7036515", "32127788"]}, {"Citation": "Kuba M.C., Turkoglu A., Oguz A., Tuncer M.C., Kaya S., Basol O., Bilge H., Tatli F. Comparison of local rosmarinic acid and topical dexpanthenol applications on wound healing in a rat experimental wound model. Folia Morphol. 2021;80:618\u2013624. doi: 10.5603/FM.a2020.0097.", "ArticleIdList": ["10.5603/FM.a2020.0097", "32844390"]}, {"Citation": "Yin Y., Xu Q., Wei X., Ma Q., Li D., Zhao J. Rosmarinic Acid-Grafted Dextran/Gelatin Hydrogel as a Wound Dressing with Improved Properties: Strong Tissue Adhesion, Antibacterial, Antioxidant and Anti-Inflammatory. Molecules. 2023;28:4034. doi: 10.3390/molecules28104034.", "ArticleIdList": ["10.3390/molecules28104034", "PMC10223410", "37241772"]}, {"Citation": "Bansal R., Poelstra K. Hepatic Stellate Cell Targeting Using Peptide-Modified Biologicals. Methods Mol. Biol. 2023;2669:269\u2013284.", "ArticleIdList": ["37247067"]}, {"Citation": "Miao C.G., Yang Y.Y., He X., Huang C., Huang Y., Zhang L., Lv X.W., Jin Y., Li J. Wnt signaling in liver fibrosis: Progress, challenges and potential directions. Biochimie. 2013;95:2326\u20132335. doi: 10.1016/j.biochi.2013.09.003.", "ArticleIdList": ["10.1016/j.biochi.2013.09.003", "24036368"]}, {"Citation": "Xu C.Y., Wang J., Zhu T.J., Shen Y., Tang X.S., Fang L., Xu Y.Z. Cross-Talking Between PPAR and WNT Signaling and its Regulation in Mesenchymal Stem Cell Differentiation. Curr. Stem Cell Res. Ther. 2016;11:247\u2013254. doi: 10.2174/1574888X10666150723145707.", "ArticleIdList": ["10.2174/1574888X10666150723145707", "26201865"]}, {"Citation": "Zhang J.J., Wang Y.L., Feng X.B., Song X.D., Liu W.B. Rosmarinic acid inhibits proliferation and induces apoptosis of hepatic stellate cells. Biol. Pharm. Bull. 2011;34:343\u2013348. doi: 10.1248/bpb.34.343.", "ArticleIdList": ["10.1248/bpb.34.343", "21372382"]}, {"Citation": "De Smet V., Eysackers N., Merens V., Kazemzadeh Dastjerd M., Halder G., Verhulst S., Mannaerts I., van Grunsven L.A. Initiation of hepatic stellate cell activation extends into chronic liver disease. Cell Death Dis. 2021;12:1110. doi: 10.1038/s41419-021-04377-1.", "ArticleIdList": ["10.1038/s41419-021-04377-1", "PMC8627507", "34839349"]}, {"Citation": "Lu C., Zou Y., Liu Y., Niu Y. Rosmarinic acid counteracts activation of hepatic stellate cells via inhibiting the ROS-dependent MMP-2 activity: Involvement of Nrf2 antioxidant system. Toxicol. Appl. Pharmacol. 2017;318:69\u201378. doi: 10.1016/j.taap.2017.01.008.", "ArticleIdList": ["10.1016/j.taap.2017.01.008", "28115189"]}, {"Citation": "Yang T., Shen D.P., Wang Q.L., Tao Y.Y., Liu C.H. Investigation of the absorbed and metabolized components of Danshen from Fuzheng Huayu recipe and study on the anti-hepatic fibrosis effects of these components. J. Ethnopharmacol. 2013;148:691\u2013700. doi: 10.1016/j.jep.2013.05.031.", "ArticleIdList": ["10.1016/j.jep.2013.05.031", "23707207"]}, {"Citation": "Yang T., Liu S., Wang C.H., Tao Y.Y., Zhou H., Liu C.H. Comparative pharmacokinetic and tissue distribution profiles of four major bioactive components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe. J. Pharm. Biomed. Anal. 2015;114:152\u2013158. doi: 10.1016/j.jpba.2015.05.014.", "ArticleIdList": ["10.1016/j.jpba.2015.05.014", "26048667"]}, {"Citation": "Yang J., Antin P., Berx G., Blanpain C., Brabletz T., Bronner M., Campbell K., Cano A., Casanova J., Christofori G., et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 2020;21:341\u2013352. doi: 10.1038/s41580-020-0237-9.", "ArticleIdList": ["10.1038/s41580-020-0237-9", "PMC7250738", "32300252"]}, {"Citation": "Dongre A., Weinberg R.A. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol. 2019;20:69\u201384. doi: 10.1038/s41580-018-0080-4.", "ArticleIdList": ["10.1038/s41580-018-0080-4", "30459476"]}, {"Citation": "Jung H.W., Yoon C.H., Kim Y.H., Boo Y.C., Park K.M., Park Y.K. Wen-Pi-Tang-Hab-Wu-Ling-San extract inhibits the release of inflammatory mediators from LPS-stimulated mouse macrophages. J. Ethnopharmacol. 2007;114:439\u2013445. doi: 10.1016/j.jep.2007.08.035.", "ArticleIdList": ["10.1016/j.jep.2007.08.035", "17904776"]}, {"Citation": "Jung H.W., Jung J.K., Ramalingam M., Yoon C.H., Bae H.S., Park Y.K. Anti-diabetic effect of Wen-pi-tang-Hab-Wu-ling-san extract in streptozotocin-induced diabetic rats. Indian J. Pharmacol. 2012;44:97\u2013102.", "ArticleIdList": ["PMC3271549", "22345879"]}, {"Citation": "Su Z., Wang X., Gao X., Liu Y., Pan C., Hu H., Beyer R.P., Shi M., Zhou J., Zhang J., et al. Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease. J. Intern. Med. 2014;276:470\u2013485. doi: 10.1111/joim.12214.", "ArticleIdList": ["10.1111/joim.12214", "24494798"]}, {"Citation": "Fei Q., Ma H., Zou J., Wang W., Zhu L., Deng H., Meng M., Tan S., Zhang H., Xiao X., et al. Metformin protects against ischaemic myocardial injury by alleviating autophagy-ROS-NLRP3-mediated inflammatory response in macrophages. J. Mol. Cell Cardiol. 2020;145:1\u201313. doi: 10.1016/j.yjmcc.2020.05.016.", "ArticleIdList": ["10.1016/j.yjmcc.2020.05.016", "32470468"]}, {"Citation": "Zhang X., Zhu J.X., Ma Z.G., Wu H.M., Xu S.C., Song P., Kong C.Y., Yuan Y.P., Deng W., Tang Q.Z. Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity. Int. J. Biol. Sci. 2019;15:556\u2013567. doi: 10.7150/ijbs.29907.", "ArticleIdList": ["10.7150/ijbs.29907", "PMC6367577", "30745842"]}, {"Citation": "Bahri S., Ali R.B., Abdennabi R., Nahdi A., Mlika M., Jameleddine S. Industrial Elimination of Essential Oils from Rosmarinus officinalis: In Support of the Synergic Antifibrotic Effect of Rosmarinic and Carnosic Acids in Bleomycin Model of Lung Fibrosis. Nutr. Cancer. 2021;73:2376\u20132387. doi: 10.1080/01635581.2020.1826991.", "ArticleIdList": ["10.1080/01635581.2020.1826991", "33059466"]}, {"Citation": "Tang J., Xiang Z., Bernards M.T., Chen S. Peritoneal adhesions: Occurrence, prevention and experimental models. Acta Biomater. 2020;116:84\u2013104. doi: 10.1016/j.actbio.2020.08.036.", "ArticleIdList": ["10.1016/j.actbio.2020.08.036", "32871282"]}, {"Citation": "Oelhafen K., Shayota B.J., Muhleman M., Klaassen Z., Shoja M.M., Tubbs R.S., Loukas M. Peritoneal bands: A review of anatomical distribution and clinical implications. Am. Surg. 2012;78:377\u2013384. doi: 10.1177/000313481207800424.", "ArticleIdList": ["10.1177/000313481207800424", "22472391"]}, {"Citation": "de Paula F., Teshima T.H.N., Hsieh R., Souza M.M., Nico M.M.S., Lourenco S.V. Overview of Human Salivary Glands: Highlights of Morphology and Developing Processes. Anat. Rec. 2017;300:1180\u20131188. doi: 10.1002/ar.23569.", "ArticleIdList": ["10.1002/ar.23569", "28192873"]}, {"Citation": "Castelli J., Simon A., Louvel G., Henry O., Chajon E., Nassef M., Haigron P., Cazoulat G., Ospina J.D., Jegoux F., et al. Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia. Radiat. Oncol. 2015;10:6. doi: 10.1186/s13014-014-0318-z.", "ArticleIdList": ["10.1186/s13014-014-0318-z", "PMC4311461", "25573091"]}, {"Citation": "Shahraki T., Arabi A., Feizi S. Pterygium: An update on pathophysiology, clinical features, and management. Ther. Adv. Ophthalmol. 2021;13:25158414211020152. doi: 10.1177/25158414211020152.", "ArticleIdList": ["10.1177/25158414211020152", "PMC8170279", "34104871"]}, {"Citation": "Chen Y.Y., Tsai C.F., Tsai M.C., Chen W.K., Hsu Y.W., Lu F.J. Anti-fibrotic effect of rosmarinic acid on inhibition of pterygium epithelial cells. Int. J. Ophthalmol. 2018;11:189\u2013195.", "ArticleIdList": ["PMC5824070", "29487805"]}, {"Citation": "Cin B., Ciloglu N.S., Omar S., Kaya Terzi N. Effect of Rosmarinic Acid and Alcohol on Fat Graft Survival in Rat Model. Aesthetic Plast. Surg. 2020;44:177\u2013185. doi: 10.1007/s00266-019-01519-x.", "ArticleIdList": ["10.1007/s00266-019-01519-x", "31637505"]}, {"Citation": "Yeh C.W., Wu W.J., Lu C.W., Wang S.E., Chuang W.C., Lee M.C., Wu C.H. Traditional Chinese Medicine Yang-Gan-Wan Alleviated Experimental Hepatic Damage by Inhibiting Oxidation, Inflammation, and Apoptosis in Cell and Mouse Models. Evid. Based Complement. Altern. Med. 2021;2021:556352. doi: 10.1155/2021/2556352.", "ArticleIdList": ["10.1155/2021/2556352", "PMC8514921", "34659428"]}, {"Citation": "Deguchi Y., Ito M. Rosmarinic acid in Perilla frutescens and perilla herb analyzed by HPLC. J. Nat. Med. 2020;74:341\u2013352. doi: 10.1007/s11418-019-01367-8.", "ArticleIdList": ["10.1007/s11418-019-01367-8", "31848798"]}, {"Citation": "Yong C., Zhang Z., Huang G., Yang Y., Zhu Y., Qian L., Tian F., Liu L., Wu Q., Xu Z., et al. Exploring the Critical Components and Therapeutic Mechanisms of Perilla frutescens L. in the Treatment of Chronic Kidney Disease via Network Pharmacology. Front. Pharmacol. 2021;12:717744. doi: 10.3389/fphar.2021.717744.", "ArticleIdList": ["10.3389/fphar.2021.717744", "PMC8662752", "34899287"]}, {"Citation": "Levsh O., Pluskal T., Carballo V., Mitchell A.J., Weng J.K. Independent evolution of rosmarinic acid biosynthesis in two sister families under the Lamiids clade of flowering plants. J. Biol. Chem. 2019;294:15193\u201315205. doi: 10.1074/jbc.RA119.010454.", "ArticleIdList": ["10.1074/jbc.RA119.010454", "PMC6802498", "31481469"]}, {"Citation": "Lamichane S., Dahal Lamichane B., Kwon S.M. Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis. Int. J. Mol. Sci. 2018;19:949. doi: 10.3390/ijms19040949.", "ArticleIdList": ["10.3390/ijms19040949", "PMC5979443", "29565812"]}, {"Citation": "Montaigne D., Butruille L., Staels B. PPAR control of metabolism and cardiovascular functions. Nat. Rev. Cardiol. 2021;18:809\u2013823. doi: 10.1038/s41569-021-00569-6.", "ArticleIdList": ["10.1038/s41569-021-00569-6", "34127848"]}, {"Citation": "Li Z., Luo L., Yu W., Li P., Ou D., Liu J., Ma H., Sun Q., Liang A., Huang C., et al. PPARgamma phase separates with RXRalpha at PPREs to regulate target gene expression. Cell Discov. 2022;8:37. doi: 10.1038/s41421-022-00388-0.", "ArticleIdList": ["10.1038/s41421-022-00388-0", "PMC9043196", "35473936"]}, {"Citation": "Mihaylov S.R., Castelli L.M., Lin Y.H., Gul A., Soni N., Hastings C., Flynn H.R., Paun O., Dickman M.J., Snijders A.P., et al. The master energy homeostasis regulator PGC-1alpha exhibits an mRNA nuclear export function. Nat. Commun. 2023;14:5496. doi: 10.1038/s41467-023-41304-8.", "ArticleIdList": ["10.1038/s41467-023-41304-8", "PMC10485026", "37679383"]}, {"Citation": "Kokeny G., Calvier L., Hansmann G. PPARgamma and TGFbeta-Major Regulators of Metabolism, Inflammation, and Fibrosis in the Lungs and Kidneys. Int. J. Mol. Sci. 2021;22:10431. doi: 10.3390/ijms221910431.", "ArticleIdList": ["10.3390/ijms221910431", "PMC8508998", "34638771"]}, {"Citation": "Gowans G.J., Hardie D.G. AMPK: A cellular energy sensor primarily regulated by AMP. Biochem. Soc. Trans. 2014;42:71\u201375. doi: 10.1042/BST20130244.", "ArticleIdList": ["10.1042/BST20130244", "PMC5703408", "24450630"]}, {"Citation": "Herzig S., Shaw R.J. AMPK: Guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell Biol. 2018;19:121\u2013135. doi: 10.1038/nrm.2017.95.", "ArticleIdList": ["10.1038/nrm.2017.95", "PMC5780224", "28974774"]}, {"Citation": "Steinberg G.R., Hardie D.G. New insights into activation and function of the AMPK. Nat. Rev. Mol. Cell Biol. 2022;24:255\u2013272. doi: 10.1038/s41580-022-00547-x.", "ArticleIdList": ["10.1038/s41580-022-00547-x", "36316383"]}, {"Citation": "Tonelli C., Chio I.I.C., Tuveson D.A. Transcriptional Regulation by Nrf2. Antioxid. Redox Signal. 2018;29:1727\u20131745. doi: 10.1089/ars.2017.7342.", "ArticleIdList": ["10.1089/ars.2017.7342", "PMC6208165", "28899199"]}, {"Citation": "He F., Ru X., Wen T. NRF2, a Transcription Factor for Stress Response and Beyond. Int. J. Mol. Sci. 2020;21:4777. doi: 10.3390/ijms21134777.", "ArticleIdList": ["10.3390/ijms21134777", "PMC7369905", "32640524"]}, {"Citation": "Boo Y.C. Natural Nrf2 Modulators for Skin Protection. Antioxidants. 2020;9:812. doi: 10.3390/antiox9090812.", "ArticleIdList": ["10.3390/antiox9090812", "PMC7556038", "32882952"]}, {"Citation": "Kuga A., Tsuchida K., Panda H., Horiuchi M., Otsuki A., Taguchi K., Katsuoka F., Suzuki M., Yamamoto M. The beta-TrCP-Mediated Pathway Cooperates with the Keap1-Mediated Pathway in Nrf2 Degradation In Vivo. Mol. Cell Biol. 2022;42:e0056321. doi: 10.1128/mcb.00563-21.", "ArticleIdList": ["10.1128/mcb.00563-21", "PMC9302178", "35674451"]}, {"Citation": "Liu T., Zhang L.Y., Joo D., Sun S.C. NF-\u03baB signaling in inflammation. Signal Transduct. Target. Ther. 2017;2:17023. doi: 10.1038/sigtrans.2017.23.", "ArticleIdList": ["10.1038/sigtrans.2017.23", "PMC5661633", "29158945"]}, {"Citation": "Sun S.C. The non-canonical NF-\u03baB pathway in immunity and inflammation. Nat. Rev. Immunol. 2017;17:545\u2013558. doi: 10.1038/nri.2017.52.", "ArticleIdList": ["10.1038/nri.2017.52", "PMC5753586", "28580957"]}, {"Citation": "Yu H., Lin L.B., Zhang Z.Q., Zhang H.Y., Hu H.B. Targeting NF-\u03baB pathway for the therapy of diseases: Mechanism and clinical study. Signal Transduct. Target. Ther. 2020;5:209. doi: 10.1038/s41392-020-00312-6.", "ArticleIdList": ["10.1038/s41392-020-00312-6", "PMC7506548", "32958760"]}, {"Citation": "Khojasteh A., Mirjalili M.H., Alcalde M.A., Cusido R.M., Eibl R., Palazon J. Powerful Plant Antioxidants: A New Biosustainable Approach to the Production of Rosmarinic Acid. Antioxidants. 2020;9:1273. doi: 10.3390/antiox9121273.", "ArticleIdList": ["10.3390/antiox9121273", "PMC7765155", "33327619"]}, {"Citation": "Swamy M.K., Sinniah U.R., Ghasemzadeh A. Anticancer potential of rosmarinic acid and its improved production through biotechnological interventions and functional genomics. Appl. Microbiol. Biotechnol. 2018;102:7775\u20137793. doi: 10.1007/s00253-018-9223-y.", "ArticleIdList": ["10.1007/s00253-018-9223-y", "30022261"]}, {"Citation": "Garc\u00eda-Melero J., L\u00f3pez-Mitjavila J.J., Garc\u00eda-Celma M.J., Rodriguez-Abreu C., Grijalvo S. Rosmarinic Acid-Loaded Polymeric Nanoparticles Prepared by Low-Energy Nano-Emulsion Templating: Formulation, Biophysical Characterization, and In Vitro Studies. Materials. 2022;15:4572. doi: 10.3390/ma15134572.", "ArticleIdList": ["10.3390/ma15134572", "PMC9267406", "35806696"]}, {"Citation": "Chung C.H., Jung W., Keum H., Kim T.W., Jon S. Nanoparticles Derived from the Natural Antioxidant Rosmarinic Acid Ameliorate Acute Inflammatory Bowel Disease. Acs Nano. 2020;14:6887\u20136896. doi: 10.1021/acsnano.0c01018.", "ArticleIdList": ["10.1021/acsnano.0c01018", "32449857"]}, {"Citation": "Hitl M., Kladar N., Gavaric N., Bozin B. Rosmarinic Acid-Human Pharmacokinetics and Health Benefits. Planta Med. 2021;87:273\u2013282. doi: 10.1055/a-1301-8648.", "ArticleIdList": ["10.1055/a-1301-8648", "33285594"]}, {"Citation": "Min J.B., Chen H., Gong Z.P., Liu X., Wu T., Li W.R., Fang J.S., Huang T.L., Zhang Y.F., Zhao W., et al. Pharmacokinetic and Pharmacodynamic Properties of Rosmarinic Acid in Rat Cholestatic Liver Injury. Molecules. 2018;23:2287. doi: 10.3390/molecules23092287.", "ArticleIdList": ["10.3390/molecules23092287", "PMC6225135", "30205454"]}]}], "History": [{"Year": "2023", "Month": "12", "Day": "11"}, {"Year": "2024", "Month": "1", "Day": "22"}, {"Year": "2024", "Month": "1", "Day": "23"}, {"Year": "2024", "Month": "2", "Day": "24", "Hour": "11", "Minute": "44"}, {"Year": "2024", "Month": "2", "Day": "24", "Hour": "11", "Minute": "43"}, {"Year": "2024", "Month": "2", "Day": "24", "Hour": "1", "Minute": "9"}, {"Year": "2024", "Month": "1", "Day": "24"}], "PublicationStatus": "epublish", "ArticleIdList": ["38397744", "PMC10886237", "10.3390/antiox13020146", "antiox13020146"]}}]}